Effects of CD28 blockade on subsets of naïve T cells in cats

American Journal of Veterinary Research

Volumn 66, Issue 3, 2005, Pages 483-492

  Aronson, Lillian R ^a   Drobatz, Kenneth J ^a   Hunter, Christopher A ^a   Mason, Nicola ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CONCANAVALIN A; CYCLOSPORIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DEXAMETHASONE; IONOMYCIN; MITOGENIC AGENT; PHORBOL 13 ACETATE 12 MYRISTATE; STEROID; THYMIDINE; TRITIUM;

ANIMAL CELL; ARTICLE; CAT; CELL STIMULATION; CONTROLLED STUDY; DRUG MECHANISM; FLOW CYTOMETRY; IN VITRO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; MEMORY CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; T LYMPHOCYTE SUBPOPULATION; TOXOPLASMA GONDII;

ANIMALS; ANTIGENS, PROTOZOAN; CATS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CONCANAVALIN A; CYCLOSPORINE; DEXAMETHASONE; FLOW CYTOMETRY; IMMUNOCONJUGATES; IMMUNOLOGIC MEMORY; IMMUNOSUPPRESSION; IONOMYCIN; LEUKOCYTES, MONONUCLEAR; TETRADECANOYLPHORBOL ACETATE; TOXOPLASMA;

ANIMALIA; FELIS CATUS; TOXOPLASMA; TOXOPLASMA GONDII; TRITIUM;

EID: 17544374367     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2005.66.483     Document Type: Article

References (43)

1. Bernsteen L, Gregory CR, Aronson LR, et al. Acute toxoplasmosis following renal transplantation in three cats and a dog. J Am Vet Med Assoc 1999;215:1123-1126.
2. Bretscher P, Cohn M. A theory of self-nonself discrimination. Science 1970;169:1042-1049.
3. Najafian N, Sayegh MH. CTLA4-Ig: a novel immunosuppressive agent. Expert Opin Investig Drugs 2000;9:2147-2157.
4. Schaub M, Stadlbauer THW, Chandraker A, et al. Comparative strategies to induce long-term graft acceptance in fully allogeneic renal versus cardiac allograft models by CD28-B7 T cell costimulatory blockade: role of thymus and spleen. J Am Soc Nephrol 1998;9:891-898.
5. Bolling SF, Lin H, Wei RQ, et al. The effect of combination cyclosporine and CTLA4-Ig therapy on cardiac allograft survival. J Surg Res 1994;57:60-64.
6. Permin PJ, Scott D, Davis TA, et al. Opposing effects of CTLA4-Ig and anti-CD80 (B7-1) plus anti-CD86 (B7-2) on experimental allergic encephalomyelitis. J Neuroimmunol 1996;65:31-39.
7. Hale DA, Gottschalk R, Maki T, et al. Use of CTLA4-Ig in combination with conventional immunosuppressive agents to prolong allograft survival. Transplantation 1997;64:897-900.
8. Kirk AD, Harlan DM, Armstrong NN, et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci U S A 1997;94:8789-8794.
9. Kurlberg G, Haglind E, Schon K, et al. Blockade of the B7-CD28 pathway by CTLA4-Ig counteracts rejection and prolongs survival in small bowel transplantation. Scand J Immunol 2000;51:224-230.
10. Turka LA, Linsley PS, Lin H, et al. T-cell activation by CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci U S A 1992;89:11102-11105.
11. Sayegh MH, Zheng XG, Magee C, et al. Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients. Transplantation 1997;64:1646-1650.
12. Russell ME, Hancock WW, Akalin E, et al. Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4-Ig modulates T cell and macrophage activation and attenuates arteriosclerosis. J Clin Invest 1996;97:833-838.
13. Azuman H, Chandraker A, Nadeau K, et al. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci U S A 1996;93:12439-12444.
14. Lin H, Bollong SF, Linsley PS, et al. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4-Ig plus donor-specific transfusions. J Exp Med 1993;178:1801-1806.
15. Chandraker A, Azuma H, Nadeau K, et al. Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection. J Clin Invest 1998;101:2309-2318.
16. Akalin E, Chandraker A, Russell ME, et al. CD28-B7 T cell costimulatory blockade by CTLA4-Ig in the rat renal allograft model. Transplantation 1996;62:1942-1945.
17. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993;11:191-212.
18. Harris NL, Peach RJ, Ronchese F. CTLA4-Ig inhibits optimal T helper 2 cell development but not protective immunity or memory response to Nippostrongylus brasiliensis. Eur J Immunol 1999;29:311-316.
19. Suresh M, Whitmire JK, Harrington LE, et al. Role of CD28-B7 interactions in generation and maintenance of CD8 T cell memory. J Immunol 2001;167:5565-5573.
20. Boyum A. A one-stage procedure for isolation of granulocytes and lymphocytes from human blood. General sedimentation properties of white blood cells in a 1g gravity field. Scand J Clin Lab Invest Suppl 1968;97:51-76.
21. Wells AD, Gudmundsdottir H, Turka LA. Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J Clin Invest 1997;100:3173-3183.
22. Sharma SD, Mullenax J, Araujo FG, et al. Western blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies. J Immunol 1983;131:977-983.
23. Royston P. An extension of Shapiro and Wilk's W test of normality. Appl Stat 1982;31:115-124.
24. Royston P. Approximating the Shapiro-Wilk W test for non-normality. Stat Computing 1992;2:117-119.
25. Royston P. A toolkit for testing non-normality in complete and censored samples. Statistician 1993;42:37-43.
26. Shapiro S, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika 1965;52:591-611.
27. Gregory CR, Taylor NJ, Willits NH, et al. Response to isoantigens and mitogens in the cat: effects of cyclosporine A. Am J Vet Res 1987;48:126-130.
28. Tan P, Anasetti C, Hansen JA, et al. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J Exp Med 1993;177:165-173.
29. Bugeon L, Dallman MJ. Costimulation of T cells. Am J Respir Crit Care Med 2000;162:S164-S168.
30. Gudmundsdottir H, Wells AD, Turka LA. Dynamics and requirements of T cell clonal expansion in vivo at the single-cell level: effector function is linked to proliferative capacity. J Immunol 1999;162:5212-5223.
31. Gao D, Li J, Orosz CG, et al. Different costimulation signals used by CD4+ and CD8+ cells that independently initiate rejection of allogenic hepatocytes in mice. Hepatology 2000;32:1018-1028.
32. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996;14:233-258.
33. June CH, Ledbetter JA, Linsley PS. Role of the CD28 receptor in T cell activation. Immunol Today 1990;11:211-216.
34. Reddy B, Gupta S, Chuzhin Y, et al. The effect of CD28/B7 blockade on alloreactive T and B cells after liver cell transplantation. Transplantation 2001;71:801-811.
35. Newell KA, He G, Guo Z, et al. Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells. J Immunol 1999; 163:2358-2362.
36. Halloran PF, Leung Lui S. Approved immunosuppressants. In: Norman DJ, Suki WN, eds. Primer on transplantation. Thorofare, NJ: American Society of Transplant Physicians, 1998;93-102.
37. Hunter CA, Ellis-Neyer L, Gabriel KE, et al. The role of the CD28/B7 interaction in the regulation of NK cell responses during infection with Toxoplasma gondii. J Immunol 1997;158:2285-2293.
38. Haczku A, Alexander A, Brown P, et al. The effect of dexametahsone, cyclosporine, and rapamycin on T-lymphocyte proliferation in vitro: comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma. J Allergy Clin Immunol 1994;93:510-519.
39. Ramirez F, Silva A. Glucocorticoids enhance concanavalin A-induced mitogenic response through the inhibition of nitric oxide production. Immunology 1997;90:66-73.
40. Metzger Z, Hoffeld JT, Oppenheim JJ. Macrophage-mediated suppression. I. Evidence for participation of both hydrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation. J Immunol 1980;124:983-988.
41. Gordon D, Nouri AME. Comparison of the inhibition by glucocorticosteroids and cyclosporine A of mitogen-stimulated human lymphocyte proliferation. Clin Exp Immunol 1981;44:287-294.
42. Chikanza IC, Panayi GS. The effect of hydrocortisone on in vitro lymphocyte proliferation and interleukin-2 and -4 production in corticosteroid sensitive and resistant subjects. Eur J Clin Invest 1993;23:845-850.
43. Wiegers GJ, Croiset G, Reul JM, et al. Differential effects of corticosteroids on rat peripheral blood T-lymphocyte mitogenesis in vivo and in vitro. Am J Physiol 1993;265:E825-E830.